Published March 2021 | Version v1
Journal article

Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas

  • 1. Laboratory for Preventive and Personalized Medicine (MPP Lab), University of Brescia (Italy)
  • 2. Department of Molecular and Translational Medicine, Via Branze 39, 25123, Brescia, University of Brescia (Italy)
  • 3. cFRU Lab, Università degli Studi di Brescia, Viale Europa 11, 25123, Brescia (Italy)

Description

Highlights: • CAM supports the growth and differentiation of embryonic stem cells into teratomas. • In teratomas, parenchymal Embryonic stem cell-derived endothelial cells form chimeric vessels with stromal endothelial cells. • CAM allows the simultaneously characterization of vasculogenesis and angiogenesis processes. Tumor neovascularization may occur via both angiogenic and vasculogenic events. In order to investigate the vessel formation during tumor growth, we developed a novel experimental model that takes into account the differentiative and tumorigenic properties of Embryonic Stem cells (ESCs). Leukemia Inhibitory Factor-deprived murine ESCs were grafted on the top of the chick embryo chorionallantoic membrane (CAM) in ovo. Cell grafts progressively grew, forming a vascularized mass within 10 days. At this stage, the grafts are formed by cells with differentiative features representative of all three germ layers, thus originating teratomas, a germinal cell tumor. In addition, ESC supports neovascular events by recruiting host capillaries from surrounding tissue that infiltrates the tumor mass. Moreover, immunofluorescence studies demonstrate that perfused active blood vessels within the tumor are of both avian and murine origin because of the simultaneous occurrence of angiogenic and vasculogenic events. In conclusion, the chick embryo ESC/CAM-derived teratoma model may represent a useful approach to investigate both vasculogenic and angiogenic events during tumor growth and for the study of natural and synthetic modulators of the two processes.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.yexcr.2021.112490

Additional details

Identifiers

DOI
10.1016/j.yexcr.2021.112490;
PII
S0014482721000215;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
400
Journal Issue
2
Journal Page Range
vp.
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53118957
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANGIOGENESIS; ANIMAL TISSUES; CAPILLARIES; EMBRYOS; GRAFTS; LEUKEMIA; STEM CELLS
Descriptors DEC
ANIMAL CELLS; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; DISEASES; IMMUNE SYSTEM DISEASES; NEOPLASMS; ORGANS; SOMATIC CELLS; TRANSPLANTS

Optional Information

Copyright
Copyright (c) 2021 Published by Elsevier Inc.